Type 10 Soluble Adenylyl Cyclase Is Overexpressed in Prostate Carcinoma and Controls Proliferation of Prostate Cancer Cells*

Background: Soluble adenylyl cyclase (sAC) may be an alternative intracellular localized source of cAMP controlling proliferation. Results: sAC is overexpressed in prostate carcinoma, and inhibition of sAC leads to cell cycle arrest. Conclusion: sAC controls proliferation of prostate carcinoma cells. Significance: sAC represents a novel pathway promoting proliferation in cancer cells and is a promising target for prostate cancer treatment. cAMP signaling plays an essential role in modulating the proliferation of different cell types, including cancer cells. Until now, the regulation of this pathway was restricted to the transmembrane class of adenylyl cyclases. In this study, significant overexpression of soluble adenylyl cyclase (sAC), an alternative source of cAMP, was found in human prostate carcinoma, and therefore, the contribution of this cyclase was investigated in the prostate carcinoma cell lines LNCaP and PC3. Suppression of sAC activity by treatment with the sAC-specific inhibitor KH7 or by sAC-specific knockdown mediated by siRNA or shRNA transfection prevented the proliferation of prostate carcinoma cells, led to lactate dehydrogenase release, and induced apoptosis. Cell cycle analysis revealed a significant rise in the G2 phase population 12 h after sAC inhibition, which was accompanied by the down-regulation of cyclin B1 and CDK1. sAC-dependent regulation of proliferation involves the EPAC/Rap1/B-Raf signaling pathway. In contrast, protein kinase A does not play a role. In conclusion, this study suggests a novel sAC-dependent signaling pathway that controls the proliferation of prostate carcinoma cells.

[1]  C. Magro,et al.  Soluble adenylyl cyclase antibody profile as a diagnostic adjunct in the assessment of pigmented lesions. , 2012, Archives of dermatology.

[2]  L. Pott,et al.  Type 10 adenylyl cyclase mediates mitochondrial Bax translocation and apoptosis of adult rat cardiomyocytes under simulated ischaemia/reperfusion. , 2012, Cardiovascular research.

[3]  Lifeng Liu,et al.  CCL21/CCR7 Promotes G2/M Phase Progression via the ERK Pathway in Human Non-Small Cell Lung Cancer Cells , 2011, PloS one.

[4]  K. Fizazi,et al.  Targeting Continued Androgen Receptor Signaling in Prostate Cancer , 2011, Clinical Cancer Research.

[5]  L. Persani,et al.  8-Chloro-Cyclic AMP and Protein Kinase A I-Selective Cyclic AMP Analogs Inhibit Cancer Cell Growth through Different Mechanisms , 2011, PloS one.

[6]  M. Tresguerres,et al.  Intracellular cAMP signaling by soluble adenylyl cyclase. , 2011, Kidney international.

[7]  D. Merkle,et al.  Roles of cAMP and cAMP-dependent protein kinase in the progression of prostate cancer: cross-talk with the androgen receptor. , 2011, Cellular signalling.

[8]  Yih-Jer Wu,et al.  PKA and Epac synergistically inhibit smooth muscle cell proliferation , 2011, Journal of molecular and cellular cardiology.

[9]  E. Stanbridge,et al.  Mitogen-activated protein/extracellular signal-regulated kinase kinase 1act/tubulin interaction is an important determinant of mitotic stability in cultured HT1080 human fibrosarcoma cells. , 2010, Cancer research.

[10]  M. Nowycky,et al.  Exchange protein directly activated by cyclic AMP increases melanoma cell migration by a Ca2+-dependent mechanism. , 2010, Cancer research.

[11]  L. Levin,et al.  Soluble adenylyl cyclase defines a nuclear cAMP microdomain in keratinocyte hyperproliferative skin diseases. , 2010, The Journal of investigative dermatology.

[12]  S. Pizzo,et al.  Epac1‐induced cellular proliferation in prostate cancer cells is mediated by B‐Raf/ERK and mTOR signaling cascades , 2009, Journal of cellular biochemistry.

[13]  Brian O. Smith,et al.  EPAC proteins transduce diverse cellular actions of cAMP , 2009, British journal of pharmacology.

[14]  Bin Wang,et al.  Sustained cyclic AMP production by parathyroid hormone receptor endocytosis. , 2009, Nature chemical biology.

[15]  M. Lohse,et al.  Persistent cAMP-Signals Triggered by Internalized G-Protein–Coupled Receptors , 2009, PLoS biology.

[16]  Sanjeev Kumar,et al.  Soluble Adenylyl Cyclase Controls Mitochondria-dependent Apoptosis in Coronary Endothelial Cells* , 2009, Journal of Biological Chemistry.

[17]  R. Acín-Pérez,et al.  Cyclic AMP produced inside mitochondria regulates oxidative phosphorylation. , 2009, Cell metabolism.

[18]  L. Cornelius,et al.  Down-regulation of Rap1GAP via promoter hypermethylation promotes melanoma cell proliferation, survival, and migration. , 2009, Cancer research.

[19]  M. Tresguerres,et al.  Somatic ‘Soluble’ Adenylyl Cyclase Isoforms Are Unaffected in Sacytm1Lex/Sacytm1Lex ‘Knockout’ Mice , 2008, PloS one.

[20]  Yongping Cui,et al.  Knockdown of B-Raf impairs spindle formation and the mitotic checkpoint in human somatic cells , 2008, Cell cycle.

[21]  D. Hochbaum,et al.  Epac, in Synergy with cAMP-dependent Protein Kinase (PKA), Is Required for cAMP-mediated Mitogenesis* , 2008, Journal of Biological Chemistry.

[22]  P. Ricchi,et al.  PGE2 inhibits apoptosis in human adenocarcinoma Caco-2 cell line through Ras-PI3K association and cAMP-dependent kinase A activation. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[23]  G. Parmigiani,et al.  The Consensus Coding Sequences of Human Breast and Colorectal Cancers , 2006, Science.

[24]  S. Jaffrey,et al.  Soluble adenylyl cyclase is required for netrin-1 signaling in nerve growth cones , 2006, Nature Neuroscience.

[25]  L. Pott,et al.  Gene silencing in adult rat cardiac myocytes in vitro by adenovirus-mediated RNA interference , 2006, Journal of Muscle Research & Cell Motility.

[26]  C. Burant,et al.  Identification of a putative tumor suppressor gene Rap1GAP in pancreatic cancer. , 2006, Cancer research.

[27]  R. Biondi,et al.  Epac activation converts cAMP from a proliferative into a differentiation signal in PC12 cells. , 2005, Molecular biology of the cell.

[28]  G. Kopf,et al.  The "soluble" adenylyl cyclase in sperm mediates multiple signaling events required for fertilization. , 2005, Developmental cell.

[29]  N. Dumaz,et al.  Integrating signals between cAMP and the RAS/RAF/MEK/ERK signalling pathways , 2005, The FEBS journal.

[30]  K. Savage,et al.  The phosphodiesterase PDE4B limits cAMP-associated PI3K/AKT-dependent apoptosis in diffuse large B-cell lymphoma. , 2005, Blood.

[31]  P. Insel,et al.  The Pro-apoptotic Protein Bim Is a Convergence Point for cAMP/Protein Kinase A- and Glucocorticoid-promoted Apoptosis of Lymphoid Cells* , 2004, Journal of Biological Chemistry.

[32]  Mitchell Cohen,et al.  Cyclic AMP Activation of the Extracellular Signal-regulated Kinases 1 and 2 , 2004, Journal of Biological Chemistry.

[33]  M. Poetsch,et al.  Microsatellite analysis at 1p36.3 in malignant melanoma of the skin: fine mapping in search of a possible tumour suppressor gene region , 2003, Melanoma research.

[34]  L. Levin,et al.  Compartmentalization of bicarbonate‐sensitive adenylyl cyclase in distinct signaling microdomains , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[35]  Xiaodong Cheng,et al.  Cell Cycle-dependent Subcellular Localization of Exchange Factor Directly Activated by cAMP* , 2002, The Journal of Biological Chemistry.

[36]  G. Tzivion,et al.  Raf-1/MEK/MAPK Pathway Is Necessary for the G2/M Transition Induced by Nocodazole* , 2000, The Journal of Biological Chemistry.

[37]  M. Cann,et al.  Soluble adenylyl cyclase as an evolutionarily conserved bicarbonate sensor. , 2000, Science.

[38]  E. Krebs,et al.  Mitogen-activated protein kinase kinase activity is required for the G(2)/M transition of the cell cycle in mammalian fibroblasts. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[39]  M. Cann,et al.  Cytosolic adenylyl cyclase defines a unique signaling molecule in mammals. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[40]  R. Zidovetzki,et al.  Up-regulation of the cAMP/PKA pathway inhibits proliferation, induces differentiation, and leads to apoptosis in malignant gliomas. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[41]  D. Barnes,et al.  Immunohistochemical determination of oestrogen receptor: comparison of different methods of assessment of staining and correlation with clinical outcome of breast cancer patients. , 1996, British Journal of Cancer.